Kairos Archives - Kairos Ventures

Domicell

By: Charissa On: December 22, 2022 In:

CytoDel

By: Charissa On: December 8, 2022 In:

Stoicheia

By: Charissa On: April 8, 2021 In:

Stoicheia is revolutionizing the way we discover new materials, especially materials fit for specific tasks and able to meet...

Vivodyne

By: Charissa On: April 8, 2021 In:

Vivodyne is changing how scientists study human biology & develop therapeutics. Their platform technology creates a new preclinical drug...

Actinia

By: Charissa On: February 26, 2021 In:

Actinia develops radiation detection solutions for medical imaging, nuclear energy applications, and non-proliferation of illicit radioactive materials.

Novosteo

By: Charissa On: November 23, 2020 In:

Quince Therapeutics, previously Cortexyme, is a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases. Cortexyme acquired...